WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:WNDM Medical Inc (WNDM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7866
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone bleeding. Its product finds application in all except third degree burns, acute wounds, and chronic wounds. WNDM Medical discovers, develops, and markets advanced wound care products. The company has license agreement with Applied Nutritional for patented technologies and processes related to CellerateRX. It markets its products through independent distributors, healthcare distributors, distributor organizations, and sales representatives. WNDM Medical is headquartered in Fort Worth, Texas, the US.

WNDM Medical Inc (WNDM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
WNDM Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
WNDM Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
WNDM Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
WNDM Medical Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Wound Management Technologies Raises USD0.2 Million in Rights Offering of Shares 10
Wound Management Technologies Announces Private Placement Of Shares For US$2.4 Million 11
Debt Offering 12
Wound Management Technologies Raises USD0.5 Million in Private Placement of 10% Notes 12
Wound Management Technologies Raises USD0.4 Million in Public Offering of Debentures Due 2015 13
Acquisition 14
Wound Management Technologies Completes Divestment Of Secure eHealth 14
WNDM Medical Inc – Key Competitors 15
WNDM Medical Inc – Key Employees 16
WNDM Medical Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 19
Financial Announcements 19
Jul 12, 2018: WNDM Medical Announces Record Sales for the Second Quarter of 2018 – Up 56% over Second Quarter 2017 19
Mar 29, 2018: Wound Management Technologies Announces Record Annual Sales Ending December 31, 2017 – Up 14% over 2016 20
Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter 21
May 17, 2017: Wound Management Issues 2017 10Q and Hires New Strategic Marketing Director 22
Apr 27, 2017: Q1 2017 Sales Up 32% Over Q1 2016, for Wound Management Technologies 23
Feb 14, 2017: Wound Management Technologies Announces Record Quarterly and Annual Sales Ending December 31, 2016 – Up 147% over Q4 2015, and 63% over 2015 24
Corporate Communications 25
Feb 15, 2018: Wound Management Technologies Announces J. Michael Carmena Appointed Chief Executive Officer 25
Mar 08, 2017: Wound Management announces appointment of John Siedhoff as Chairman 26
Legal and Regulatory 27
Apr 03, 2018: Wound Management Technologies Changes Name to WNDM Medical 27
Other Significant Developments 28
Aug 28, 2018: WNDM Medical is partnering with the Catalyst Group 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
WNDM Medical Inc, Medical Equipment, Key Facts, 2017 2
WNDM Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
WNDM Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
WNDM Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Deals By Market, 2012 to YTD 2018 8
WNDM Medical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Wound Management Technologies Raises USD0.2 Million in Rights Offering of Shares 10
Wound Management Technologies Announces Private Placement Of Shares For US$2.4 Million 11
Wound Management Technologies Raises USD0.5 Million in Private Placement of 10% Notes 12
Wound Management Technologies Raises USD0.4 Million in Public Offering of Debentures Due 2015 13
Wound Management Technologies Completes Divestment Of Secure eHealth 14
WNDM Medical Inc, Key Competitors 15
WNDM Medical Inc, Key Employees 16
WNDM Medical Inc, Subsidiaries 17
WNDM Medical Inc, Joint Venture 17

List of Figures
WNDM Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
WNDM Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
WNDM Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
WNDM Medical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
WNDM Medical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
WNDM Medical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
WNDM Medical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
WNDM Medical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[WNDM Medical Inc (WNDM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wolters Kluwer N.V. (WKL):企業の財務・戦略的SWOT分析
    Wolters Kluwer N.V. (WKL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. Its lead clinical program product candidate include VK5211, an orally available, non-steroidal selective an …
  • Great Wall Motor Co Ltd:企業の戦略・SWOT・財務情報
    Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Great Wall Motor Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Eguana Technologies Inc. (EGT):電力:M&Aディール及び事業提携情報
    Summary Eguana Technologies Inc. (Eguana), formerly Sustainable Energy Technologies Ltd, is a power electronics company that designs, manufactures and supplies high performance power control solutions for grid interactive energy storage systems. The company’s power control solutions charge and disch …
  • Cibis SpA:企業の戦略・SWOT・財務分析
    Cibis SpA - Strategy, SWOT and Corporate Finance Report Summary Cibis SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Nestle Health Science SA-医療機器分野:企業M&A・提携分析
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • Natural Alternatives International Inc (NAII):企業の財務・戦略的SWOT分析
    Summary Natural Alternatives International Inc (NAI) is a formulator and manufacturer of customized nutritional supplements. The company manufactures and distributes the only patented beta-alanine supplement on the market. It offers services such as science-based product formulation, raw material ac …
  • Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc is a biopharmaceutical company that offers research, development and commercialization of prescription drugs. The company offers products such as Onemia and CaPre. Its CaPre is developed for the prevention a …
  • Air Water Inc (4088):企業の財務・戦略的SWOT分析
    Air Water Inc (4088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Anika Therapeutics Inc (ANIK):企業の製品パイプライン分析2018
    Summary Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for tissue protection, repair and regeneration. It offers solutions for orthobiologics, dermal, ophthalmic, surgical and veterinary applications. Its major products include viscosupplementation and regene …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AvidBiotics Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary AvidBiotics Corp (AvidBiotics) is a pharmaceutical company that develops non-antibody therapeutic proteins targeting cancer cells, virus-infected cells and pathogenic bacteria. The company develops a portfolio of therapeutic protein candidates and protein engineering platforms which include …
  • Blade Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Blade Therapeutics Inc (Blade Therapeutics) is a biopharmaceutical company that develops novel anti-fibrotic therapies to treat various fibrotic disorders. The company’s lead program is a small molecule inhibitor targeting an intracellular cysteine protease associated with fibrosis across di …
  • Sprint Bioscience AB (SPRINT):製薬・医療:M&Aディール及び事業提携情報
    Summary Sprint Bioscience AB (Sprint Bioscience) is a developer of pharmaceutical products in the areas of cancer and metabolism. The company develops STK25, a drug candidate against a new target protein for the treatment of type 2 diabetes; VPS34, a drug candidate for the treatment of various types …
  • Weight Watchers International, Inc.:企業の戦略・SWOT・財務分析
    Weight Watchers International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Weight Watchers International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Tandem Diabetes Care Inc (TNDM):企業の財務・戦略的SWOT分析
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also pro …
  • JBCC Holdings Inc (9889):企業の戦略的SWOT分析
    JBCC Holdings Inc (9889) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Glide Pharmaceutical Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Glide Pharmaceutical Technologies Ltd (Glide Technologies), formerly Caretek Medical Ltd, is a clinical stage development company that concentrates on development and delivery of solid dose formulations of vaccines and therapeutics. Its technology portfolio includes Glide SDI, a solid dose i …
  • Stemcor Global Holdings Ltd:企業の戦略・SWOT・財務情報
    Stemcor Global Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Stemcor Global Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Laboratoire HRA Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Laboratoire HRA Pharma (HRA Pharma) is a healthcare products provider that offers women’s health and endocrinology products. The company offers a wide range of women’s health products which include emergency contraception, uterine fibroids, regular contraception and genital herp products amo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆